4.7 Article

Lactobacillus ferrnentum CJL-112 protects mice against influenza virus infection by activating T-helper 1 and eliciting a protective immune response

Journal

INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 18, Issue 1, Pages 50-54

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.intimp.2013.10.020

Keywords

Lactobacillus fermentum CJL-112; Influenza virus; Nitric oxide production; Th1 immune response; IgA

Ask authors/readers for more resources

We have previously reported that nasally administered Lactobacillus fermentum CJL-112 (CJL-112) efficiently improves resistance against lethal influenza infection in both mice and chicken. The aim of the present study was to understand the underlying mechanisms of the significant anti-influenza activity of this lactobacilli strain. In vitro, co-culturing of the chicken macrophage cell line HD-11 with CJL-112 significantly increased nitric oxide (NO) production. In vivo, CJL-112 was nasally administered to BALB/c mice for 21 days prior to influenza A/NWS/33 (H1N1) virus (IFV) infection. Significant up-regulation of T-helper 1 (Th1) cytokines (IL-2, IFN-gamma) was observed, while the levels of T-helper 2 (Th2) cytoldnes (IL-4, IL-5, IL-10) was either reduced or unchanged than that in control mice were. Furthermore, IgA and specific anti-influenza IgA levels increased significantly in the treated mice than those in untreated mice. Therefore, CJL-112 likely protects the mice against lethal IFV infection via stimulation of macrophages, activation of Th1 and augmentation of IgA production, when directly delivered into the respiratory tract. (C) 2013 Published by Elsevier B.V.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available